|
ZNF41 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.0666000000007E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.1610999999997E-05 |
| Normal-vs-Stage2 |
1.648190E-01 |
| Normal-vs-Stage3 |
3.403800E-02 |
| Normal-vs-Stage4 |
8.43369999999899E-05 |
| Stage1-vs-Stage2 |
4.826000E-01 |
| Stage1-vs-Stage3 |
6.523600E-01 |
| Stage1-vs-Stage4 |
2.730600E-01 |
| Stage2-vs-Stage3 |
8.122800E-01 |
| Stage2-vs-Stage4 |
2.096600E-01 |
| Stage3-vs-Stage4 |
2.148600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.00950000000178E-05 |
| Normal-vs-AfricanAmerican |
9.964900E-03 |
| Normal-vs-Asian |
8.177800E-02 |
| Caucasian-vs-AfricanAmerican |
5.229000E-01 |
| Caucasian-vs-Asian |
8.148800E-01 |
| AfricanAmerican-vs-Asian |
9.965600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66469999995922E-06 |
| Normal-vs-Female |
2.998400E-01 |
| Male-vs-Female |
4.622400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.961000E-04 |
| Normal-vs-Extreme_Weight |
2.18669999999532E-05 |
| Normal-vs-Obese |
3.040300E-02 |
| Normal-vs-Extreme_Obese |
6.023800E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.737600E-01 |
| Normal_Weight-vs-Obese |
2.038000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.716000E-01 |
| Extreme_Weight-vs-Obese |
7.940300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.444200E-01 |
| Obese-vs-Extreme_Obese |
4.817400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.357800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.376240E-02 |
| Normal-vs-Age(61-80Yrs) |
2.53930000004843E-06 |
| Normal-vs-Age(81-100Yrs) |
1.25259999994576E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.513600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.419000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.174100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.964400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.421200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.316610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.46339999999678E-05 |
| Normal-VS-Type2 PRCC |
1.14190000000125E-06 |
| Normal-VS-KIRP CIMP |
5.182400E-01 |
| Normal-VS-Unclassified PRCC |
5.235800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.720160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.384000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.107600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.355240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.214000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.052800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16909999961601E-07 |
| Normal-vs-N1 |
1.074020E-01 |
| Normal-vs-N2 |
1.740250E-03 |
| N0-vs-N1 |
1.096220E-01 |
| N0-vs-N2 |
4.509600E-01 |
| N1-vs-N2 |
2.495800E-01 |
|
|
